UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

Blood, 1996-07, Vol.88 (1), p.335-340

1996

Volltextzugriff (PDF)

Effects of In Vivo Recombinant Methionyl Human Granulocyte Colony-Stimulating Factor on the Neutrophil Response and Peripheral Blood Colony-Forming Cells in Healthy Young and Elderly Adult Volunteers

Blood, 1994-11, Vol.84 (9), p.2923-2929

1994

Volltextzugriff (PDF)

In Vivo Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutrophil Oxidative Functions in Normal Human Volunteers

The Journal of infectious diseases, 1997-05, Vol.175 (5), p.1184-1192

1997

Volltextzugriff (PDF)

Aging and Marrow Neutrophil Reserves

Journal of the American Geriatrics Society (JAGS), 1994-01, Vol.42 (1), p.77-81

1994

Volltextzugriff (PDF)

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

The New England journal of medicine, 2012-09, Vol.367 (13), p.1187-1197

2012

Volltextzugriff (PDF)

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study ( SWOG 9235)

Urology (Ridgewood, N.J.), 2001-07, Vol.58 (1), p.53-58

2001

Volltextzugriff (PDF)

A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy

Anti-cancer drugs, 2013-08, Vol.24 (7), p.743-753

2013

Volltextzugriff (PDF)

Abnormal Responsiveness of Granulocyte-Committed Progenitor Cells in Cyclic Neutropenia

Blood, 1992-05, Vol.79 (10), p.2536-2539

1992

Volltextzugriff (PDF)

Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors

Drugs & aging, 1996-07, Vol.9 (1), p.37-47

1996

Volltextzugriff (PDF)

Intrathecal Cytotoxic T-Cell Immunotherapy for Metastatic Leptomeningeal Melanoma

Clinical cancer research, 2001-03, Vol.7 (3), p.917s-924s

2001

Volltextzugriff (PDF)

Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy

The Journal of immunology (1950), 1997-07, Vol.159 (1), p.472-480

1997

Volltextzugriff (PDF)

Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo

The Journal of immunology (1950), 2005-05, Vol.174 (9), p.5490-5498

2005

Volltextzugriff (PDF)

T Cells Specific for a Polymorphic Segment of CD45 Induce Graft-Versus-Host Disease with Predominant Pulmonary Vasculitis

The Journal of immunology (1950), 1998-07, Vol.161 (2), p.909-918

1998

Volltextzugriff (PDF)

A phase II trial of dasatinib in subjects with hormone-refractory prostate cancer previously treated with chemotherapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4575-4575

2011

Volltextzugriff (PDF)

Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3

Journal of gerontology (Kirkwood), 1993-09, Vol.48 (5), p.M207-M212

1993

Volltextzugriff (PDF)

A phase I study of the safety and immunogenicity of a therapeutic vaccine, DPX-0907 in patients with advanced-stage ovarian, breast, or prostate cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13050-e13050

2011

Volltextzugriff (PDF)

A dose-finding study of a MUC-1 vaccine in conjunction with poly-IC:LC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxy methylcellulose) in immunosuppressed (IS) patients (pts) with advanced prostate cancer (PCa)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2564-2564

2011

Volltextzugriff (PDF)

A randomized phase II study of pazopanib in castrate-sensitive prostate cancer: A University of Chicago phase II consortium/DoD Prostate Cancer Clinical Trials Consortium study

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.170-170

2011

Volltextzugriff (PDF)

Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides

The Journal of immunology (1950), 2005-09, Vol.175 (5), p.3045-3052

2005

Volltextzugriff (PDF)

Small Rho GTPases Regulate Antigen Presentation in Dendritic Cells

The Journal of immunology (1950), 2005-03, Vol.174 (6), p.3394-3400

2005

Volltextzugriff (PDF)

Differential regulation of proto-oncogenes c-jun and c-fos in T lymphocytes activated through CD28

The Journal of immunology (1950), 1994-12, Vol.153 (12), p.5393-5401

1994

Volltextzugriff (PDF)

Phase II study of vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in patients with advanced transitional cell urothelial cancer (TCC) after platinum-based therapy—California Cancer Consortium/University of Pittsburgh NCI/CTEP-sponsored trial

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16058-16058

2008

Volltextzugriff (PDF)

Docetaxel and imatinib every 21 days for castration resistant prostate cancer: A phase II trial

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16086-e16086

2009

Volltextzugriff (PDF)

Satraplatin in patients with advanced hormone-refractory prostate cancer (HRPC): Overall survival (OS) results from the phase III satraplatin and prednisone against refractory cancer (SPARC) trial

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5003-5003

2008

Volltextzugriff (PDF)

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

Blood, 1996-07, Vol.88 (1), p.335-340

1996

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(95)

Sprache

Englisch
(93)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

Effects of In Vivo Recombinant Methionyl Human Granulocyte Colony-Stimulating Factor on the Neutrophil Response and Peripheral Blood Colony-Forming Cells in Healthy Young and Elderly Adult Volunteers

In Vivo Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutrophil Oxidative Functions in Normal Human Volunteers

Aging and Marrow Neutrophil Reserves

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study ( SWOG 9235)

A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy

Abnormal Responsiveness of Granulocyte-Committed Progenitor Cells in Cyclic Neutropenia

Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors

Intrathecal Cytotoxic T-Cell Immunotherapy for Metastatic Leptomeningeal Melanoma

Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy

Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo

T Cells Specific for a Polymorphic Segment of CD45 Induce Graft-Versus-Host Disease with Predominant Pulmonary Vasculitis

A phase II trial of dasatinib in subjects with hormone-refractory prostate cancer previously treated with chemotherapy

Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3

A phase I study of the safety and immunogenicity of a therapeutic vaccine, DPX-0907 in patients with advanced-stage ovarian, breast, or prostate cancer

A dose-finding study of a MUC-1 vaccine in conjunction with poly-IC:LC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxy methylcellulose) in immunosuppressed (IS) patients (pts) with advanced prostate cancer (PCa)

A randomized phase II study of pazopanib in castrate-sensitive prostate cancer: A University of Chicago phase II consortium/DoD Prostate Cancer Clinical Trials Consortium study

Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides

Small Rho GTPases Regulate Antigen Presentation in Dendritic Cells

Differential regulation of proto-oncogenes c-jun and c-fos in T lymphocytes activated through CD28

Phase II study of vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in patients with advanced transitional cell urothelial cancer (TCC) after platinum-based therapy—California Cancer Consortium/University of Pittsburgh NCI/CTEP-sponsored trial

Docetaxel and imatinib every 21 days for castration resistant prostate cancer: A phase II trial

Satraplatin in patients with advanced hormone-refractory prostate cancer (HRPC): Overall survival (OS) results from the phase III satraplatin and prednisone against refractory cancer (SPARC) trial

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

Suchergebnisse filtern